Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GUFIC BIOSCIENCE vs ISTREET NETWORK - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GUFIC BIOSCIENCE ISTREET NETWORK GUFIC BIOSCIENCE/
ISTREET NETWORK
 
P/E (TTM) x 47.6 -49.7 - View Chart
P/BV x 7.6 - - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 GUFIC BIOSCIENCE   ISTREET NETWORK
EQUITY SHARE DATA
    GUFIC BIOSCIENCE
Mar-24
ISTREET NETWORK
Mar-24
GUFIC BIOSCIENCE/
ISTREET NETWORK
5-Yr Chart
Click to enlarge
High Rs3643 11,304.3%   
Low Rs1821 12,879.4%   
Sales per share (Unadj.) Rs80.40-  
Earnings per share (Unadj.) Rs8.6-0.1 -14,182.7%  
Cash flow per share (Unadj.) Rs10.3-0.1 -16,984.7%  
Dividends per share (Unadj.) Rs0.100-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs53.1-0.8 -6,412.6%  
Shares outstanding (eoy) m100.2821.30 470.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.40-  
Avg P/E ratio x31.8-38.2 -83.2%  
P/CF ratio (eoy) x26.5-38.2 -69.5%  
Price / Book Value ratio x5.1-2.8 -183.8%  
Dividend payout %1.20-   
Avg Mkt Cap Rs m27,35649 55,477.0%   
No. of employees `000NANA-   
Total wages/salary Rs m1,0960 353,632.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m8,0670-  
Other income Rs m220 217,700.0%   
Total revenues Rs m8,0880 80,884,300.0%   
Gross profit Rs m1,459-1 -112,208.5%  
Depreciation Rs m1700-   
Interest Rs m1540-   
Profit before tax Rs m1,157-1 -89,668.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2950-   
Profit after tax Rs m861-1 -66,772.1%  
Gross profit margin %18.10- 
Effective tax rate %25.50-   
Net profit margin %10.70- 
BALANCE SHEET DATA
Current assets Rs m6,0051 454,908.3%   
Current liabilities Rs m3,7202 206,693.9%   
Net working cap to sales %28.30- 
Current ratio x1.60.7 220.1%  
Inventory Days Days120- 
Debtors Days Days1,4930- 
Net fixed assets Rs m4,9211 592,845.8%   
Share capital Rs m10085 117.7%   
"Free" reserves Rs m5,225-103 -5,081.0%   
Net worth Rs m5,326-18 -30,190.5%   
Long term debt Rs m1,54018 8,553.5%   
Total assets Rs m10,9252 505,806.0%  
Interest coverage x8.50-  
Debt to equity ratio x0.3-1.0 -28.3%  
Sales to assets ratio x0.70-   
Return on assets %9.3-59.8 -15.5%  
Return on equity %16.27.3 220.8%  
Return on capital %19.1-358.9 -5.3%  
Exports to sales %11.30-  
Imports to sales %25.40-  
Exports (fob) Rs m911NA-   
Imports (cif) Rs m2,048NA-   
Fx inflow Rs m9110-   
Fx outflow Rs m2,0480-   
Net fx Rs m-1,1380-   
CASH FLOW
From Operations Rs m-75-1 7,101.9%  
From Investments Rs m-1,024NA -10,238,900.0%  
From Financial Activity Rs m824NA-  
Net Cashflow Rs m-275-1 26,408.7%  

Share Holding

Indian Promoters % 72.5 46.2 156.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.7 0.0 -  
FIIs % 0.2 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 27.5 53.8 51.1%  
Shareholders   32,825 11,450 286.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GUFIC BIOSCIENCE With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on GUFIC BIOSCIENCE vs PRINCIPAL PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GUFIC BIOSCIENCE vs PRINCIPAL PHARMA Share Price Performance

Period GUFIC BIOSCIENCE PRINCIPAL PHARMA S&P BSE HEALTHCARE
1-Day -1.15% 0.00% 1.23%
1-Month -7.18% -7.35% -0.24%
1-Year 30.36% 30.71% 43.62%
3-Year CAGR 29.66% 10.10% 20.35%
5-Year CAGR 43.50% 9.08% 26.24%

* Compound Annual Growth Rate

Here are more details on the GUFIC BIOSCIENCE share price and the PRINCIPAL PHARMA share price.

Moving on to shareholding structures...

The promoters of GUFIC BIOSCIENCE hold a 72.5% stake in the company. In case of PRINCIPAL PHARMA the stake stands at 46.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GUFIC BIOSCIENCE and the shareholding pattern of PRINCIPAL PHARMA.

Finally, a word on dividends...

In the most recent financial year, GUFIC BIOSCIENCE paid a dividend of Rs 0.1 per share. This amounted to a Dividend Payout ratio of 1.2%.

PRINCIPAL PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of GUFIC BIOSCIENCE, and the dividend history of PRINCIPAL PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.